FDA Issues Draft Charter for CDRH Center Science Council


FDA CDRH Center Science Council will Serve as an Internal Advisory and Decision-Making Body on Various Issues, Including Clinical Data Requirements and Trials

The Food and Drug Administration (FDA) issued a draft charter of the Center for Devices and Radiological Health (CDRH) Center Science Council (CSC) and fact sheet on March 31 that describes its responsibilities and organization.i The formation of the CSC was recommended in FDA’s August 2010 510(k) Working Group and Utilization of Science in Regulatory Decision Making Task Force Reports. Its purpose is to help CDRH better identify and incorporate evolving science and technology into regulatory decision-making and enhance both communication and utilization of scientific knowledge throughout the Center. The Chairperson of the CSC is the CDRH Deputy Center Director for Science, Dr. William Maisel.

Responsibilities of the CSC. The draft charter defines five core responsibilities:

- Identification and Incorporation of New Science into Regulatory Decision-Making. The CSC is charged with aiding in the establishment of standard procedures and business processes for determining, among other things, how CDRH reacts to new information, when external experts, stakeholders or other parties are needed to address new information, and when new information requires a change in regulatory policy.

- Oversight of Issues Related to Clinical Data and Clinical Trials. The CSC is responsible for developing standard procedures for assuring consistency in decisions related to clinical trials. In carrying out this responsibility, the CSC may, among other things, establish criteria for first-in-man clinical trials; put in place a device feasibility program that would facilitate iterative device design modifications based on pre-clinical and early human data; and determine when post-market clinical requirements, including clinical trial designs, should be changed based on new scientific information.

Please see full Alert below for further information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Written by:


King & Spalding on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.